Legislative and regulatory matters are critically important for life sciences companies. The lawyers in Foley Hoag’s Government Strategies Practice have extensive experience in the development and implementation of legislation and regulations affecting the biotechnology, pharmaceutical, medical device, and health care provider industries. The regulatory environment can pose significant burdens to life sciences companies, but intelligent strategic advocacy in Congress and before federal regulatory agencies can also open up new markets and opportunities for innovative products. Lawyers at Foley Hoag work directly with Congressional staff and federal agencies, including the Food and Drug Administration (FDA) and the Centers for Medicare & Medicaid Services (CMS), on a variety of matters relating to the life sciences.
Focuses include:
- Biotechnology, Pharmaceuticals and Medical Devices
- Legislative
- Coverage and Reimbursement
- Food and Drug
- Bioterrorism and Pandemic Preparedness
Download the Foley Hoag Life Sciences: Government Strategies Datasheet (.pdf)